Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 4
1955 1
1956 1
1959 1
1964 3
1965 9
1966 3
1967 11
1968 7
1969 22
1970 14
1971 8
1972 8
1973 7
1974 13
1975 10
1976 6
1977 12
1978 7
1979 8
1980 7
1981 3
1982 6
1983 5
1984 7
1985 9
1986 5
1987 9
1988 12
1989 7
1990 13
1991 16
1992 17
1993 17
1994 27
1995 21
1996 34
1997 34
1998 37
1999 34
2000 55
2001 44
2002 61
2003 65
2004 70
2005 82
2006 80
2007 75
2008 77
2009 85
2010 101
2011 122
2012 113
2013 132
2014 123
2015 121
2016 114
2017 115
2018 105
2019 119
2020 105
2021 112
2022 107
2023 72
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

2,522 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-10 and the interleukin-10 receptor.
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Moore KW, et al. Annu Rev Immunol. 2001;19:683-765. doi: 10.1146/annurev.immunol.19.1.683. Annu Rev Immunol. 2001. PMID: 11244051 Review.
B cell depletion therapies in autoimmune disease: advances and mechanistic insights.
Lee DSW, Rojas OL, Gommerman JL. Lee DSW, et al. Nat Rev Drug Discov. 2021 Mar;20(3):179-199. doi: 10.1038/s41573-020-00092-2. Epub 2020 Dec 15. Nat Rev Drug Discov. 2021. PMID: 33324003 Free PMC article. Review.
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather active participants in autoimmune aetiology. This has been fuelled in part by the clinical success of B cell depletion therapies (BCDTs). Originally conceived as a method of elimina …
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather active participants in autoimmune aetiology. Thi …
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota.
Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, Phillips D, Weinstock GM, Fontana L, Cross AH, Zhou Y, Piccio L. Cignarella F, et al. Cell Metab. 2018 Jun 5;27(6):1222-1235.e6. doi: 10.1016/j.cmet.2018.05.006. Cell Metab. 2018. PMID: 29874567 Free PMC article. Clinical Trial.
Multiple sclerosis (MS) is more common in western countries with diet being a potential contributing factor. Here we show that intermittent fasting (IF) ameliorated clinical course and pathology of the MS model, experimental autoimmune encephalomyelitis (EAE). ...Fe …
Multiple sclerosis (MS) is more common in western countries with diet being a potential contributing factor. Here we show that intermittent …
Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
Bahr LS, Bock M, Liebscher D, Bellmann-Strobl J, Franz L, Prüß A, Schumann D, Piper SK, Kessler CS, Steckhan N, Michalsen A, Paul F, Mähler A. Bahr LS, et al. Trials. 2020 Jan 2;21(1):3. doi: 10.1186/s13063-019-3928-9. Trials. 2020. PMID: 31898518 Free PMC article. Clinical Trial.
However, clinical evidence on these diets is scarce. In the clinical study protocol presented here, we investigate whether a KD and a FD are superior to a standard diet (SD) in terms of therapeutic effects and disease progression. ...TRIAL REGISTRATION: Clini …
However, clinical evidence on these diets is scarce. In the clinical study protocol presented here, we investigate whether a K …
Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
Kim DY, Lee JS, Park SY, Kim SJ, Son CG. Kim DY, et al. J Transl Med. 2020 Jan 6;18(1):7. doi: 10.1186/s12967-019-02196-9. J Transl Med. 2020. PMID: 31906979 Free PMC article. Review.
BACKGROUND: Although medical requirements are urgent, no effective intervention has been proven for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). To facilitate the development of new therapeutics, we systematically reviewed the randomized controlled t …
BACKGROUND: Although medical requirements are urgent, no effective intervention has been proven for chronic fatigue syndrome/myalgic ence …
Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
Cash A, Kaufman DL. Cash A, et al. J Transl Med. 2022 Jun 28;20(1):295. doi: 10.1186/s12967-022-03488-3. J Transl Med. 2022. PMID: 35764955 Free PMC article. Clinical Trial.
BACKGROUND: There is no approved pharmaceutical intervention for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS). Fatigue in these patients can last for decades. ...METHODS: ME/CFS and Long-COVID patients were enrolled in an open label dose escalating "Proof o …
BACKGROUND: There is no approved pharmaceutical intervention for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS). Fatigu …
Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Sentañes RS, Alegre-Martin J. Castro-Marrero J, et al. Nutrients. 2021 Jul 30;13(8):2658. doi: 10.3390/nu13082658. Nutrients. 2021. PMID: 34444817 Free PMC article. Clinical Trial.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem, and profoundly debilitating neuroimmune disease, probably of post-viral multifactorial etiology. ...This study aimed to examine whether oral coenzyme Q10 and NADH (reduced form of nicoti …
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem, and profoundly debilitating neuroimmune diseas …
Endothelial dysfunction in ME/CFS patients.
Sandvik MK, Sørland K, Leirgul E, Rekeland IG, Stavland CS, Mella O, Fluge Ø. Sandvik MK, et al. PLoS One. 2023 Feb 2;18(2):e0280942. doi: 10.1371/journal.pone.0280942. eCollection 2023. PLoS One. 2023. PMID: 36730360 Free PMC article. Clinical Trial.
STUDY DESIGN: The study was a substudy of the RituxME trial, a national, multicenter, randomized, double-blind, placebo-controlled phase III study on the effect of rituximab vs. placebo in ME/CFS patients in Norway. ...CONCLUSIONS: ME/CFS patients had reduced macro- …
STUDY DESIGN: The study was a substudy of the RituxME trial, a national, multicenter, randomized, double-blind, placebo-contro …
Tumefactive Acute Disseminated Encephalomyelitis.
Z Ghali MG. Z Ghali MG. Neurol India. 2020 Jan-Feb;68(1):35-41. doi: 10.4103/0028-3886.279688. Neurol India. 2020. PMID: 32129240 Free article. Review.
Although this has been described and characterized for multiple sclerosis, it has been reported in a few cases in patients with acute disseminated encephalomyelitis (ADEM) within the past decade. While it may be challenging to establish a diagnosis of tumefactive ADEM acco …
Although this has been described and characterized for multiple sclerosis, it has been reported in a few cases in patients with acute dissem …
2,522 results